JAK1-selective inhibitors (Ewha Womans University/KOREA PHARMA)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameJAK1-selective inhibitors (Ewha Womans University/KOREA PHARMA)
Drug Alias NameJanus kinase 1-selective inhibitors (Ewha Womans University/KOREA PHARMA)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEwha Woman'S University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea Pharma Co LtdEwha Woman'S University
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A